Your browser doesn't support javascript.
loading
Men a conjugate vaccine: could it change epidemiology of meningococcal meningitis in Africa
Weekly Epidemiological Monitor. 2008; 01 (13): 1
en Inglés | IMEMR | ID: emr-131875
ABSTRACT
Phase 2 clinical study to assess safety and immunogenicity of meningococcal A [Men A] conjugate vaccine is currently ongoing in Mali and Gambia. The results of the study, which covers children 12- to 23-month-old [the younger age group targeted by mass vaccination campaigns], is expected to be available during the first quarter of 2008. Other studies targeting 2- to 29-year-old [the older age group targeted by the mass vaccination campaigns] are currently going on in four countries Mali, Gambia, Senegal, and India. In addition, a study protocol for use of Men A conjugate vaccine in infants has entered the ethical and regulatory submission process. The study could start as early as June 2008 in Africa
Asunto(s)
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Meningitis Meningocócica Tipo de estudio: Estudio de tamizaje Límite: Adolescente / Adulto / Niño / Child, preschool / Humanos / Lactante Idioma: Inglés Revista: Wkly. Epidemiol. Monit. Año: 2008

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Meningitis Meningocócica Tipo de estudio: Estudio de tamizaje Límite: Adolescente / Adulto / Niño / Child, preschool / Humanos / Lactante Idioma: Inglés Revista: Wkly. Epidemiol. Monit. Año: 2008